French Company Develops Promising Injectable Ivermectin

New Post Public Reply Private Reply Replies (0) Message Board
Rusty Bhawks #75920
241
French Company Develops Promising Injectable Ivermectin Treatment, But There’s a Catch
January 14, 2022

Anything that has the Bill Gates stamp of approval is instantly suspicious, and the Bill and Melinda Gates Foundation is behind the company making the Ivermectin injections.

Ivermectin has been shown by numerous studies to be effective against the coronavirus.

The fact that it’s being suppressed by our own government and panned by mainstream media tells me there’s something beneficial about the drug.

They wouldn’t call it a “horse dewormer” unless they believed it was either truly dangerous or so effective that it could derail their universal vaccine objectives.

We know it’s not the former because the government has been recommending Ivermectin for years to people coming to America from Africa.

They can’t say it’s dangerous to some but recommend it to others unless there’s a different agenda at play.

There is good reason to have hope for a new way to deliver IVM to millions of people to fight COVID variants. It offers a very sound alternative to vaccines.

With all of the considerable controversy about using IVM for treating and preventing COVID, something has slipped the attention of its supporters and critics. A relatively small French company has spent the past year or more developing an injectable product of IVM for prophylactic use and have it last in the body for months.

It has successfully completed a safety study for relatively high doses of IVM over long periods. The company tested IVM taken daily in oral form to simulate the continuous release of the active substance by a long-acting injectable. It found the results fully supportive of their injectable approach.

If the company is able to get the commercial product into the market and, if needed, get regulatory approval, their product could compete against COVID vaccines and avoid the need for the new Pfizer and Merck antiviral treatment drugs.

One can imagine that this innovative product could be just like annual flu vaccines in how it is administered to large numbers of people in a multitude of places, including medical offices, drug stores and supermarket pharmacies. And it would be wonderful if medical insurance covered it like it does for flu shots.

Here is some more information about this venture: The company is MedinCell. It has received financial support from the French government. It was started with the help of the Bill and Melinda Gates Foundation.

At its website it is possible to download a March 2021 lengthy and detailed assessment and review of IVM focusing on its history of intense global use and safety. The title is Medical Safety of Ivermectin. Here are the conclusions:

“Hundreds of millions of human subjects have been treated with ivermectin for curative or prophylactic purposes worldwide over the last 3 decades. The reference list of this report demonstrates that a large body of data is available, which allows for a detailed analysis of ivermectin medical safety.

Undoubtedly, uncertainties remain regarding ivermectin pharmacological effects and mechanisms of action, but when removed, this is not anticipated to alter the main conclusions of this report in any significant way as they rely on an extensive and consistent body of medical publications.

Taking into account all the above, the author of the present analysis of the available medical data concludes that the safety profile of ivermectin has so far been excellent in the majority of treated human patients so that ivermectin human toxicity cannot be claimed to be a serious cause for concern.”

https://truthbasedmedia.com/2022/01/14/french...s-a-catch/

Clinical Trial Conducted by MedinCell Confirms the Safety of Continuous Administration of ivermectin

https://www.businesswire.com/news/home/202104...-of-Contin
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Decoy Wines Bolsters Emmy Partnership with Creative Grant

Updated Category News Views 7

Popping Corks for Creativity: Decoy's New Chapter Stepping outside the vines and into the artistic limelight, Decoy Wines is shaking up the status quo. Announcing the launch of the Pour to What's Possible Grant, the brand is throwing down $10,000 to back creatives itching to make waves in entertainment. Now, doesn't that stand out? The Grit Behind the Grapes: Decoy's...

Continue Reading
TETRA Technologies to Engage at Key Investor Events

Updated Category News Views 1

Revving Up for Major Investor Conferences All eyes are on TETRA Technologies Inc. (NYSE:TTI) as they gear up to make splashy appearances at not one, but two high-profile investor conferences in New York. It's setting the stage for some potentially juicy conversations about where TTI, a player with deep roots in energy services, is heading in this whirlwind of an industry....

Continue Reading
Scienjoy's Strategic Stake in Education: Bold Move?

Updated Category News Views 0

Testing the Waters with Education Stake Talk about mixing oil and water. Scienjoy Holding Corporation, those tech-savvy folks from China's live streaming circles, have set their sights on education with a hefty 29.9% stake in Leader Education Limited. For HK$102.69 million, that’s about US$13.1 million, they’re jumping into an industry with a different flavor....

Continue Reading
PLAY Palm Angels Launches at Pacsun with Avani Gregg

Updated Category News Views 2

Revamping Streetwear with PLAY Palm Angels and Pacsun In a move that's making waves from the fashion runways straight into the heart of youth culture, PLAY Palm Angels is swooping into Pacsun, and they’re not just strolling in—they’re parading with a 41-piece fashion collection. Not to mention, they've snagged Avani Gregg, a powerhouse cultural influencer, to strut...

Continue Reading
HIMS Faces Class Action: Investors Eye Leadership

Updated Category News Views 0

Another Day, Another Lawsuit: Hims & Hers in Hot Water Here's the latest conundrum in the corporate world, folks. Hims & Hers Health, Inc. (NYSE: HIMS) is caught up in a class action lawsuit that could shake up the telehealth scene. Investors who found themselves knee-deep in losses during the class period from August 2025 to July 2026 might want to pay attention. The...

Continue Reading
Robo.ai Surpasses $180 Million in Q2 Revenue Surge

Updated Category News Views 7

Robo.ai's Financial Rocket Lift-off: Q2 Highlights Who would've thought a single acquisition could propel a company's revenue north of $180 million in just three months? Well, Robo.ai, with its recent grab of Quantum Core Capital (QC Capital), shattered that ceiling, showcasing what a savvy acquisition and a dash of tech wizardry can achieve. Strong Quarter, Stronger...

Continue Reading
McLean Launches Program to Foster AI Capability

Updated Category News Views 1

Driving AI Adoption: A Shift Towards Human-Centric Learning McLean & Company has dropped an initiative that’s like laying fresh tracks for AI inclusion in businesses. Dubbed the Human-Centric AI Program, it’s a wake-up call to organizations struggling to shift AI from a novelty to a natural part of operations. This isn’t just about fiddling with AI tools; it’s...

Continue Reading
Cost of Living Tops Financial Worries in 2026

Updated Category News Views 6

Financial Stress — The Silent Productivity Killer Down in the trenches of nine-to-five, it’s money that keeps stealing workers' peace of mind. The TELUS Mental Health Index shines a glaring spotlight on this, revealing that 58% of U.S. workers are most stressed by living costs. Now, that's a kicker when stacking it next to retirement or emergency savings. Those take...

Continue Reading
Kroger's Strategic Shift: Ibbotson's Bold New Charge

Updated Category News Views 0

Kroger Welcomes a Seasoned Retail Veteran Change often arrives with the dawn of new leadership. As Kroger takes a page from the playbook of large-scale retail transformation, they've enlisted Mark Ibbotson. Effective September 14, Ibbotson will step in as Executive Vice President and Chief Store Operations Officer. It's a roll of the dice that could either accelerate...

Continue Reading
York Urged to Retire Research Macaques After Probe

Updated Category News Views 3

Undercover Investigation Shakes Up York University If you thought the world of research was all about sterile labs and the pursuit of knowledge, think again. The Jane Goodall Institute (JGI), famed for championing animal welfare, has urged York University to let go of nine long-suffering rhesus macaques. Turns out, these macaques weren't exactly living their best lives....

Continue Reading

Top 5 Most Recently Viewed Articles

Discover the Exciting Launch of Super Fog Burzt Lemonade

Updated Category News Views 150

Introducing Super Fog Burzt: A Game Changer in Edibles Mfused has taken the edible cannabis industry by storm with the introduction of Super Fog Burzt, a fast-acting lemonade that is set to redefine how consumers experience cannabis edibles. Unlike traditional edibles, which can take time to kick in, Super Fog Burzt offers a quick-acting solution that allows users to...

Continue Reading
Target Hospitality Updates Bylaws for Enhanced Governance and Clarity

Updated Category News Views 89

Target Hospitality's Bylaw Amendments and Their Implications Target Hospitality Corp. (NASDAQ: TH), known for providing lodging services to sectors such as energy and construction, has recently undertaken important amendments to its bylaws, aiming to strengthen governance and improve transparency for its stockholders. This proactive step was revealed in a recent SEC...

Continue Reading
ImmunOs Therapeutics Secures Funding to Advance Cancer Trials

Updated Category News Views 140

Recent Funding Boost for ImmunOs Therapeutics AG ImmunOs Therapeutics AG, an innovative biopharmaceutical company with its own immune system modulating HLA-based technology, has successfully closed a Series C financing round, raising $11 million. This funding will help advance the development of cutting-edge cancer therapies and strengthen relationships with its...

Continue Reading
Goldman Sachs Promotes Leadership in Banking Division Amid Shares Decline

Updated Category News Views 241

Goldman Sachs Adjusts Leadership in Banking & Markets Goldman Sachs is making notable changes within its banking and markets division, ushering in a new era of leadership as part of its latest strategic move. This adjustment reflects the firm’s commitment to evolve its managerial structure and improve operational efficiency. New Leadership Appointments As reported...

Continue Reading
Otis Worldwide Corporation CEO to Engage at Major Conference

Updated Category News Views 168

Otis Worldwide Corporation CEO to Join Industry Leaders at Key Conference Otis Worldwide Corporation (NYSE: OTIS) is set to have its esteemed Chair, CEO, and President, Judy Marks, present at an influential conference hosted by Morgan Stanley. Well-known for her leadership and innovative vision, Judy Marks will participate in a fireside chat at the annual Laguna...

Continue Reading